Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Broker tips: Spectris, Inchcape, AutoTrader, JD Sports, Angle
(Sharecast News) - Shore Capital has reiterated its 'buy' rating for Spectris after an encouraging update from the precision instruments group on Thursday, saying it sees the potential for a material ratings upgrade. As of Wednesday's close, the stock was trading at a "near trough equity rating", despite significant scope for recovery and long-term growth, the broker said.
"This follows a series of downgrades, most recently on 31 October, so we expect that investors will be encouraged by this update," Shore Capital said.
Looking ahead, the broker said it sees "strong potential from recent acquisitions", which gives it increased confidence in the group's medium-term targets, such as an adjusted operating margin of 20%+ and organic growth of 6-7%.
"If these are achieved, we believe the shares would trade on a considerably higher rating, closer to peers, such as Halma, Oxford Instruments, Renishaw and Judges Scientific, which have FY25F EV/EBITDA multiples ranging from 12.8x to 23.0x. Many US-listed peers have even higher equity ratings."
Inchcape tumbled on Thursday as JPMorgan Cazenove downgrades shares of the car dealership to 'neutral' from 'overweight' and slashed the price target to 800p from 1,050p.
The bank also placed the shares on "negative catalyst watch" and said investors should "prepare for increased volatility ahead".
Citi upgraded Auto Trader to 'buy' from 'neutral' on Thursday and lifted the price target to 946p from 881p as it said it was in "pole position to outperform".
"We consider the outlook for Online Classifieds in 2025 and expect more challenged macro trends to support outperformance in autos classifieds," the bank said.
Citi said its 'buy' rating on Auto Trader is driven by the fact the company is well-positioned to benefit from the current macro environment, as car shortages continue to drive demand, supporting car prices and used car dealers.
In addition, the bank sees potential upside from Auto Trader's expansion of Deal Builder and work to expand its product offering.
Finally, it said competition remains a "peripheral factor" relative to the property classifieds.
Citi also downgraded its stance on JD Sports on Thursday to 'neutral' from 'buy' and cut its price target to 95p from 150p as it pointed to a weaker growth outlook.
The bank said it was updating estimates following soft peak trading and the company's full-year guidance downgrade.
Citi cut its forecast for FY25 like-for-like and organic growth to 0.0% and 5%, respectively, from 1.1% and 6.4% growth, previously.
The forecasts for FY26 were cut to -2.7% and +1.3%, from +1.6% and +6.9%, respectively. Citi said this reflects weak consumer sentiment and a promotional environment that JD has chosen to limit participation in, particularly in North America and the UK.
"Our reduced sales forecasts lead to FY25e EBIT margin -30 basis points versus previous estimates," it said. "We reflect the Courir acquisition, and JD's new guidance of an additional acquisition accounting-related cost for Hibbett of £6m in FY25e."
Citi cut its FY25 pre-tax profit estimate by 5% to £920m, versus consensus of £955m and guidance of £915m to £935m, while the FY26 estimate for pre-tax profit was cut 18% to £930m.
Analysts at Berenberg slashed their target price on liquid biopsy specialist Angle from 70.0p to 40.0p on Thursday but said the group was "repositioned for growth" in FY25.
Angle released a FY24 trading update on Tuesday morning, in which it said it now expects to deliver revenues of £2.9m - just below the lower end of its H1 guidance range - with its loss for the year expected to be in line with guidance.
Given the decline in revenues reported in H1, Berenberg said it was "encouraging" to see a return to growth in H2 and that management appears positive on the trajectory for FY25.
"Looking ahead, we expect further progress and expansion of the company's existing large pharma partnerships in 2025E and 2026E, with the possibility of further partnership deals to accelerate growth in the medium term," said the German bank, which has a 'buy' rating on the stock.
"For 2026E, Angle trades on 5x EV/sales. Our 40p price target is based on a risk-adjusted NPV (rNPV) approach. The reduction to our price target is largely the result of lower estimates."
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.